Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
The FEBS Journal
|
September 16, 2010
Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis
Uri Barash, Victoria Cohen-Kaplan, Ilana Dowek, et al.
Cell Communication & Adhesion
|
December 19, 2003
Vitronectin's basic domain is a syndecan ligand which functions in trans to regulate vitronectin turnover
Cynthia E Wilkins-Port, Ralph D Sanderson, Eiman Tominna-Sebald, et al.
The Journal of Biological Chemistry
|
February 3, 2012
Heparan sulfate chains of syndecan-1 regulate ectodomain shedding
Vishnu C Ramani, Pamela S Pruett, Camilla A Thompson, et al.
Cells
|
March 29, 2023
Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma
Olga Ostrovsky, Katia Beider, Hila Magen, et al.
Cancer Research
|
October 28, 2010
Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL
Yang Yang, Yongsheng Ren, Vishnu C Ramani, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
March 27, 2016
Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype
Vishnu C Ramani, Israel Vlodavsky, Mary Ng, et al.
The Journal of Biological Chemistry
|
November 26, 2015
Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions
Anurag Purushothaman, Shyam Kumar Bandari, Jian Liu, et al.
Oncotarget
|
December 2, 2015
Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma
Vishnu C Ramani, Fenghuang Zhan, Jianbo He, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 4, 2016
Heparanase: From basic research to therapeutic applications in cancer and inflammation
Israel Vlodavsky, Preeti Singh, Ilanit Boyango, et al.
Blood
|
January 26, 2010
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
Anurag Purushothaman, Toru Uyama, Fumi Kobayashi, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
The FEBS Journal
|
September 16, 2010
Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis
Uri Barash, Victoria Cohen-Kaplan, Ilana Dowek, et al.
Cell Communication & Adhesion
|
December 19, 2003
Vitronectin's basic domain is a syndecan ligand which functions in trans to regulate vitronectin turnover
Cynthia E Wilkins-Port, Ralph D Sanderson, Eiman Tominna-Sebald, et al.
The Journal of Biological Chemistry
|
February 3, 2012
Heparan sulfate chains of syndecan-1 regulate ectodomain shedding
Vishnu C Ramani, Pamela S Pruett, Camilla A Thompson, et al.
Cells
|
March 29, 2023
Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma
Olga Ostrovsky, Katia Beider, Hila Magen, et al.
Cancer Research
|
October 28, 2010
Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL
Yang Yang, Yongsheng Ren, Vishnu C Ramani, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
March 27, 2016
Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype
Vishnu C Ramani, Israel Vlodavsky, Mary Ng, et al.
The Journal of Biological Chemistry
|
November 26, 2015
Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions
Anurag Purushothaman, Shyam Kumar Bandari, Jian Liu, et al.
Oncotarget
|
December 2, 2015
Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma
Vishnu C Ramani, Fenghuang Zhan, Jianbo He, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 4, 2016
Heparanase: From basic research to therapeutic applications in cancer and inflammation
Israel Vlodavsky, Preeti Singh, Ilanit Boyango, et al.
Blood
|
January 26, 2010
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
Anurag Purushothaman, Toru Uyama, Fumi Kobayashi, et al.
Page
of 9